07:00 , Apr 14, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Melanoma Amyloid-b (A4) precursor protein-binding family B member 1 interacting protein (APBB1IP; RIAM) Studies in patient tissue and in mice suggest that inhibiting RIAM may...